Humans8,365 postmenopausal women10 yearsCohort study
Endocrine therapy adherence and 10-year cardiometabolic risk in hormone receptor-positive breast cancer
JNCI Cancer Spectrum
- Adjuvant endocrine therapy
- Aromatase inhibitors
- Lipid and ceramide metabolism
- Sex hormone signalling (oestrogen, androgen)
- Breast cancer
- Humans
The paper
Jorge R Ledesma, Joshua Nugent, Richard Cheng, Marilyn L. Kwan
Show 8 more authors
Jennifer M Specht, Cecile A Laurent, Janise Roh, Sayan Dasgupta, Allison Meisner, Samir R. Thadani, Heather Greenlee, Raymond Liu,Kaiser Permanente
JNCI Cancer Spectrum · 24 Sep 2026